Preferred Label : thiazolidinediones;
MeSH definition : THIAZOLES with two keto oxygens. Members are insulin-sensitizing agents which overcome
INSULIN RESISTANCE by activation of the peroxisome proliferator activated receptor
gamma (PPAR-gamma).;
MeSH synonym : glitazones;
CISMeF synonym : TZD;
Wikipedia automatic translation : Thiazolidinedione;
Wikipedia link : https://en.wikipedia.org/wiki/Thiazolidinedione;
Is substance : O;
Origin ID : D045162;
UMLS CUI : C1257987;
ATC code(s)
Allowable qualifiers
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
Record concept(s)
Related MeSH Supplementary Concept(s)
- AD 5075 [MeSH Supplementary Concept]
- AL 321 [MeSH Supplementary Concept]
- BFF-816 [MeSH Supplementary Concept]
- DN 108 [MeSH Supplementary Concept]
- GQ-177 [MeSH Supplementary Concept]
- MK-2305 [MeSH Supplementary Concept]
- NIP-222 [MeSH Supplementary Concept]
- OSU-53 [MeSH Supplementary Concept]
- OSU-CG5 [MeSH Supplementary Concept]
- iCRT14 [MeSH Supplementary Concept]
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
THIAZOLES with two keto oxygens. Members are insulin-sensitizing agents which overcome
INSULIN RESISTANCE by activation of the peroxisome proliferator activated receptor
gamma (PPAR-gamma).
https://www.ema.europa.eu/medicines/human/EPAR/Pioglitazone-Teva
2012
United Kingdom
English
French
summary of product characteristics
package leaflet
drug evaluation
syndication feed
drug therapy, combination
ppar gamma
drug approval
treatment outcome
administration, oral
drugs, generic
pioglitazone
diabetes mellitus, type 2
overweight
adult
aged
therapeutic equivalency
hypoglycemic agents
hypoglycemic agents
thiazolidinediones
thiazolidinediones
drug evaluation, preclinical
drug interactions
pregnancy
breast feeding
Pioglitazone Hydrochloride
Pioglitazone Hydrochloride
Pioglitazone
Pioglitazone
---
https://minerva-ebp.be/fr/article/613
false
false
minerva-ebm.be
Belgium
French
hypoglycemic agents
thiazolidinediones
diabetes mellitus, type 2
treatment outcome
glucose metabolism disorders
blood glucose
thiazolidinediones
critical appraisal or critical reading
Rosiglitazone
---
https://www.ema.europa.eu/medicines/human/EPAR/Glubrava
2012
United Kingdom
French
English
syndication feed
hypoglycemic agents
metformin
adult
drug combinations
breast feeding
pregnancy
drug approval
tablets
diabetes mellitus, type 2
drug labeling
treatment outcome
drug evaluation
drug evaluation, preclinical
hypoglycemic agents
thiazolidinediones
metformin
drug interactions
aged
administration, oral
overweight
thiazolidinediones
metformin and pioglitazone
Product containing precisely metformin hydrochloride 850 milligram and pioglitazone
(as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet
(clinical drug)
Pioglitazone Hydrochloride
Pioglitazone Hydrochloride
package leaflet
summary of product characteristics
drug evaluation
Pioglitazone
Pioglitazone
---
https://www.ema.europa.eu/medicines/human/EPAR/Avaglim
2011
United Kingdom
English
French
syndication feed
rosiglitazone maleate
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
thiazolidinediones
drug labeling
drug approval
hypoglycemic agents
sulfonylurea compounds
treatment outcome
drug evaluation
drug combinations
thiazolidinediones
diabetes mellitus, type 2
administration, oral
adult
thiazolidinediones
sulfonylurea compounds
hypoglycemic agents
aged
glimepiride
glimepiride and rosiglitazone
sulfonylurea compounds
thiazolidinediones
summary of product characteristics
drug evaluation
package leaflet
Rosiglitazone
---
http://www.has-sante.fr/portail/jcms/c_1171497/actos-pioglitazone-antidiabetique
2011
France
French
evaluation of the transparency committee
guidelines for drug use
administration, oral
hypoglycemic agents
hypoglycemic agents
insurance, health, reimbursement
pioglitazone
diabetes mellitus, type 2
overweight
thiazolidinediones
thiazolidinediones
Pioglitazone Hydrochloride
Pioglitazone Hydrochloride
Pioglitazone
Pioglitazone
---
https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2011/13617a-fra.php
2011
Canada
French
English
pharmacovigilance note
risk
canada
administration, oral
Pioglitazone Hydrochloride
hypoglycemic agents
thiazolidinediones
urinary bladder neoplasms
pioglitazone
Pioglitazone
---
http://www.ameli.fr/fileadmin/user_upload/documents/RapportEtudeCNAMTS-Pioglitazone-juin-20113.pdf
2011
France
French
technical report
Pioglitazone Hydrochloride
hypoglycemic agents
thiazolidinediones
urinary bladder neoplasms
cohort studies
incidence
urinary bladder neoplasms
Pioglitazone
---
https://smf.swisshealthweb.ch/fr/article/doi/fms.2010.07085/
2010
false
Switzerland
French
thiazolidinediones
diabetes mellitus, type 2
journal article
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-11/avandia_avandamet_-_ct-9105.pdf
http://www.has-sante.fr/portail/jcms/c_1024070/avandamet-rosiglitazone-/-metformine-association-antidiabetique
http://www.has-sante.fr/portail/jcms/c_1024080/avandia-rosiglitazone-antidiabetique
2010
France
French
guidelines for drug use
rosiglitazone
administration, oral
thiazolidinediones
hypoglycemic agents
insurance, health, reimbursement
drug combinations
metformin
diabetes mellitus, type 2
adult
overweight
aged
metformin and rosiglitazone
treatment outcome
thiazolidinediones
hypoglycemic agents
rosiglitazone maleate
rosiglitazone-metformin combination
rosiglitazone maleate
rosiglitazone-metformin combination
evaluation of the transparency committee
Rosiglitazone
Rosiglitazone
---
https://www.ema.europa.eu/medicines/human/EPAR/Avandia
2010
United Kingdom
French
English
syndication feed
diabetes mellitus, type 2
adult
hypoglycemic agents
thiazolidinediones
pregnancy
breast feeding
thiazolidinediones
hypoglycemic agents
drug evaluation, preclinical
drug approval
drug labeling
tablets
administration, oral
drug therapy, combination
treatment outcome
drug evaluation
aged
drug interactions
rosiglitazone
rosiglitazone maleate
rosiglitazone maleate
drug evaluation
package leaflet
summary of product characteristics
Rosiglitazone
Rosiglitazone
---
http://www.cbip.be/Folia/Index.cfm?FoliaWelk=F36F08G
2009
Belgium
French
thiazolidinediones
hypoglycemic agents
thiazolidinediones
hypoglycemic agents
cardiovascular diseases
risk factors
journal article
---
https://www.revmed.ch/RMS/2009/RMS-207/Thiazolidinediones-et-osteoporose
2009
Switzerland
French
bone and bones
thiazolidinediones
thiazolidinediones
journal article
---
https://minerva-ebp.be/fr/article/524
2008
minerva-ebm.be
Belgium
French
Cardiotoxicity
cardiovascular risk
thiazolidinediones
hypoglycemic agents
diabetes mellitus, type 2
myocardial infarction
heart failure
diabetes mellitus, type 2
thiazolidinediones
journal article
Rosiglitazone
---
http://www.cbip.be/Folia/Index.cfm?FoliaWelk=F34F07C
2007
Belgium
French
Cardiotoxicity
thiazolidinediones
diabetes mellitus, type 2
hypoglycemic agents
cardiovascular diseases
cardiovascular diseases
myocardial infarction
thiazolidinediones
journal article
pharmacovigilance note
Rosiglitazone
---
http://revmed.ch/RMS/2007/RMS-122/32510
2007
true
Switzerland
French
Cardiotoxicity
thiazolidinediones
hypoglycemic agents
hypoglycemic agents
risk factors
heart failure
diabetes mellitus, type 2
thiazolidinediones
clinical trials as topic
thiazolidinediones
Pioglitazone Hydrochloride
drug information
journal article
Rosiglitazone
Pioglitazone
---
https://minerva-ebp.be/fr/article/650
2007
false
false
minerva-ebm.be
Belgium
French
comparative study
diabetes mellitus, type 2
treatment outcome
glipizide
thiazolidinediones
hypoglycemic agents
aged
thiazolidinediones
critical appraisal or critical reading
Rosiglitazone
---
https://minerva-ebp.be/fr/article/586
2007
false
minerva-ebm.be
Belgium
French
Cardiotoxicity
cardiovascular diseases
hypoglycemic agents
thiazolidinediones
cardiovascular diseases
myocardial infarction
diabetes mellitus, type 2
thiazolidinediones
critical appraisal or critical reading
Rosiglitazone
---
https://rmlg.uliege.be/article/1341
2005
Belgium
French
diabetes complications
cardiovascular diseases
cardiovascular diseases
diabetes mellitus, type 2
diabetes mellitus, type 2
hypoglycemic agents
insulin
thiazolidinediones
thiazolidinediones
risk factors
journal article
---